IDXX Q4 2024 Earnings — IDEXX Laboratories, Inc. Revenue & Financial Results | Market Cap Arena

IDXXIDEXX Laboratories, Inc.

$48B

Q4 2024 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$954M+5.8% YoY

Gross Profit

$571M59.8% margin

Operating Income

$262M27.4% margin

Net Income

$216M22.7% margin

EPS (Diluted)

$2.62

QoQ Revenue Growth

-2.2%

Cash Flow

Operating Cash Flow

$262M

Free Cash Flow

$223M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$3.3B

Total Liabilities

$1.7B

Stockholders' Equity

$1.6B

Cash & Equivalents

$288M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$954M	$902M	+5.8%
Gross Profit	$571M	$526M	+8.5%
Operating Income	$262M	$245M	+6.7%
Net Income	$216M	$195M	+11.1%

Revenue Segments

Product

$560M59%

Service

$394M41%

Geographic Segments

UNITED STATES

$604M63%

EMEA

$208M22%

Asia Pacific

$83M9%

CANADA

$38M4%

Latin America

$21M2%